Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

ITW CHEMICAL PRODUCTS SCANDINAVIA ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.9% 1.9%   Bankruptcy risk   2.3% 2.5% 2.4% 1.0% 0.9% 0.9% 6.6% 6.6%   Credit score (0-100)   67 64 63 86 90 87 36 36   Credit rating   BBB BBB BBB A A A BBB BBB   Credit limit (kDKK)   1.5 0.4 0.8 2,810.1 2,933.4 2,407.1 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   56,485 57,900 61,005 26,546 21,892 23,018 0.0 0.0   EBITDA   48,644 50,951 54,224 19,105 14,499 15,852 0.0 0.0   EBIT   48,210 50,522 53,784 18,656 14,026 15,398 0.0 0.0   Pre-tax profit (PTP)   48,275.8 50,418.7 53,813.2 18,543.0 14,224.1 15,615.9 0.0 0.0   Net earnings   37,653.8 39,324.5 41,973.7 14,462.9 11,093.5 12,125.9 0.0 0.0   Pre-tax profit without non-rec. items   48,276 50,419 53,813 18,543 14,224 15,616 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   5,751 5,322 5,125 4,675 4,254 3,800 0.0 0.0   Shareholders equity total   51,367 50,692 57,665 32,128 28,222 25,348 14,348 14,348   Interest-bearing liabilities   963 1,379 1,213 978 1,464 1,361 0.0 0.0   Balance sheet total (assets)   57,345 56,377 64,870 38,480 34,964 31,535 14,348 14,348   Net Debt   963 1,379 1,213 978 1,464 1,361 -14,348 -14,348     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   56,485 57,900 61,005 26,546 21,892 23,018 0.0 0.0   Gross profit growth   2.1% 2.5% 5.4% -56.5% -17.5% 5.1% -100.0% 0.0%   Employees   13 12 12 12 12 12 0 0   Employee growth %   -27.8% -7.7% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   57,345 56,377 64,870 38,480 34,964 31,535 14,348 14,348   Balance sheet change%   -32.5% -1.7% 15.1% -40.7% -9.1% -9.8% -54.5% 0.0%   Added value   48,644.0 50,950.7 54,223.6 19,105.4 14,475.6 15,851.6 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -909 -858 -636 -900 -894 -907 -4,488 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   85.3% 87.3% 88.2% 70.3% 64.1% 66.9% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   67.8% 88.9% 88.8% 36.1% 38.7% 47.2% 0.0% 0.0%   ROI %   72.1% 95.5% 95.7% 39.9% 44.3% 54.3% 0.0% 0.0%   ROE %   57.9% 77.1% 77.5% 32.2% 36.8% 45.3% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   89.6% 89.9% 88.9% 83.5% 80.7% 80.4% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   2.0% 2.7% 2.2% 5.1% 10.1% 8.6% 0.0% 0.0%   Gearing %   1.9% 2.7% 2.1% 3.0% 5.2% 5.4% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 8.8% 0.0% 10.3% 0.0% 5.2% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   9.0 9.4 9.9 5.3 4.3 4.0 0.0 0.0   Current Ratio   9.6 10.2 10.4 5.9 5.0 4.9 0.0 0.0   Cash and cash equivalent   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   45,622.1 45,405.0 53,394.7 27,527.0 24,007.1 21,477.5 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   3,742 4,246 4,519 1,592 1,206 1,321 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   3,742 4,246 4,519 1,592 1,208 1,321 0 0   EBIT / employee   3,708 4,210 4,482 1,555 1,169 1,283 0 0   Net earnings / employee   2,896 3,277 3,498 1,205 924 1,010 0 0